Evaluation of an "Opt-Out" Inpatient Smoking Cessation Service on Smoking Behavior Study #1

Not Applicable

Active, not recruiting

• Conditions: Smoking Cessation
• Interventions: Behavioral: Enhanced Care; Behavioral: Basic Care

• Registration Number: NCT04827914
• Lead Sponsor: Medical University of South Carolina

Brief Summary

The modest goal of this study is to replicate the behavioral outcomes of the opt out MUSC-Tobacco Treatment Program in the following three patient groups: 1) psychiatric inpatients housed in the Institute of Psychiatry (IOP) in Charleston; 2) non-IOP patients seen in Charleston; and 3) patients seen in the other four MUSC affiliated hospitals combined (i.e., Chester, Florence, Lancaster, and Marion). The aims and the design/methods utilized for evaluation will be the same for each of the three patient groups.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-08
• Study First Submitted: 2021-03-30
• Study First Submitted QC: 2021-03-30
• Study First Posted: 2021-04-01
• Status Verified: 2025-04
• Last Update Submitted: 2025-04-03
• Last Update Posted: 2025-04-06
• Primary Completion: 2026-09-01
• Study Completion: 2026-09-01

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 1122

Inclusion Criteria

• 18+ years and older
• hospitalized cigarette smokers eligible for either enhanced or basic care
• discharged from the hospital back to their home

Exclusion Criteria

• patients without a phone number
• those unable to communicate in the English language

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Enhanced Care Condition	Enhanced Care	-
Basic Care Condition	Basic Care	-

Primary Outcome Measures

Name	Time	Method
Self-reported smoking prevalence 6-weeks after hospitalization.	Assessed 6-weeks post-discharge	Hypothesize that patients exposed to the enhanced care intervention compared to basic care will report a 2-fold higher 7-day non-smoker prevalence rate after hospitalization (i.e., 20% vs 10%)
Self-reported use of FDA Approved Smoking Cessation Medication	Assessed 6-weeks post-discharge	Hypothesize that patients exposed to the enhanced care intervention compared to basic care will report a 2.5-fold greater use of an FDA approved stop smoking medication after hospitalization (i.e., 20% vs 8%)

Trial Locations

Locations (2)

MUSC; 🇺🇸 Marion, South Carolina, United States

Institute of Psychiatry; 🇺🇸 Charleston, South Carolina, United States